Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

August 21, 2018

Study Completion Date

August 21, 2018

Conditions
DiabetesKidney Diseases
Interventions
DEVICE

Continuous Glucose Monitoring

"* The FreeStyle Libre Pro Flash Glucose Monitoring System is a professional continuous glucose monitoring (CGM) device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. The Freestyle Libre Pro device is FDA approved (PMA# P150021). Participants will use the FreeStyle Libre Pro Flash Glucose Monitoring device according to its approved use, on the back of the arm.~* CGM monitoring will be performed on Day 1 by placing the Freestyle Libre Pro on research subjects for intended use of 14 days.~* Subjects will be advised to return to the research site on Day 14 to remove the CGM device for analysis."

Trial Locations (1)

11021

Northwell Health (Division Endocrinology and Nephrology), Great Neck

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER